187 related articles for article (PubMed ID: 22992267)
41. Histomorphology of aberrant crypt foci in colorectal carcinoma.
Norlida AO; Phang KS
Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
[TBL] [Abstract][Full Text] [Related]
42. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
[TBL] [Abstract][Full Text] [Related]
43. Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1.
Muguruma N; Okamoto K; Nakagawa T; Sannomiya K; Fujimoto S; Mitsui Y; Kimura T; Miyamoto H; Higashijima J; Shimada M; Horino Y; Matsumoto S; Hanaoka K; Nagano T; Shibutani M; Takayama T
Sci Rep; 2017 Jul; 7(1):6536. PubMed ID: 28747791
[TBL] [Abstract][Full Text] [Related]
44. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
[TBL] [Abstract][Full Text] [Related]
45. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
[TBL] [Abstract][Full Text] [Related]
46. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Wang Y; Jin HY; Fang MZ; Wang XF; Chen H; Huang SL; Kong DS; Li M; Zhang X; Sun Y; Wang SM
World J Gastroenterol; 2020 May; 26(17):2064-2081. PubMed ID: 32536775
[TBL] [Abstract][Full Text] [Related]
47. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
48. Aberrant crypt focus size predicts distal polyp histopathology.
Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
[TBL] [Abstract][Full Text] [Related]
49. Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.
Ezuka A; Sakai E; Kawana K; Nagase H; Kakuta Y; Uchiyama S; Ohkubo H; Higurashi T; Nonaka T; Endo H; Takahashi H; Nakajima A
Oncol Lett; 2015 Dec; 10(6):3689-3695. PubMed ID: 26788192
[TBL] [Abstract][Full Text] [Related]
50. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.
Figueiredo P; Donato M; Urbano M; Goulão H; Gouveia H; Sofia C; Leitão M; Freitas D
Int J Colorectal Dis; 2009 Apr; 24(4):441-50. PubMed ID: 18769883
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.
Kearney KE; Pretlow TG; Pretlow TP
Int J Cancer; 2009 Jul; 125(1):249-52. PubMed ID: 19358283
[TBL] [Abstract][Full Text] [Related]
52. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
[TBL] [Abstract][Full Text] [Related]
53. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
[TBL] [Abstract][Full Text] [Related]
54. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
55. Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.
Imchen T; Manasse J; Min KW; Baek SJ
Exp Toxicol Pathol; 2013 Sep; 65(6):919-24. PubMed ID: 23369238
[TBL] [Abstract][Full Text] [Related]
56. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
[TBL] [Abstract][Full Text] [Related]
57. Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial.
Adams KF; Lampe PD; Newton KM; Ylvisaker JT; Feld A; Myerson D; Emerson SS; White E; Potter JD; Lampe JW
Am J Clin Nutr; 2005 Sep; 82(3):620-6. PubMed ID: 16155276
[TBL] [Abstract][Full Text] [Related]
58. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
[TBL] [Abstract][Full Text] [Related]
59. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial.
Bostick RM; Fosdick L; Wood JR; Grambsch P; Grandits GA; Lillemoe TJ; Louis TA; Potter JD
J Natl Cancer Inst; 1995 Sep; 87(17):1307-15. PubMed ID: 7658483
[TBL] [Abstract][Full Text] [Related]
60. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
